Glimisave M2 Forte Tablet PR is a combination oral hypoglycemic agent containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and enhancing peripheral glucose uptake and utilization, improving insulin sensitivity. This synergistic combination offers effective glycemic control by addressing both insulin secretion and insulin resistance. Glimisave M2 Forte Tablet PR is typically prescribed when monotherapy with either agent is insufficient to achieve target glycemic levels. It is recommended to be taken orally with meals to minimize gastrointestinal side effects commonly associated with Metformin. Patients should undergo regular monitoring of blood glucose, renal function, and hepatic parameters during therapy. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to hypoxia. Common adverse effects may include hypoglycemia, gastrointestinal disturbances such as nausea, vomiting, and diarrhea, and rarely, lactic acidosis. This medication should be used under medical supervision with appropriate lifestyle modifications including diet and exercise for optimal diabetes management.

Dosage & How to Use